These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 29385885)

  • 1. LRRK2 Phosphorylation: Behind the Scenes.
    De Wit T; Baekelandt V; Lobbestael E
    Neuroscientist; 2018 Oct; 24(5):486-500. PubMed ID: 29385885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 Phosphorylation.
    Nichols RJ
    Adv Neurobiol; 2017; 14():51-70. PubMed ID: 28353278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.
    Marchand A; Sarchione A; Athanasopoulos PS; Roy HB; Goveas L; Magnez R; Drouyer M; Emanuele M; Ho FY; Liberelle M; Melnyk P; Lebègue N; Thuru X; Nichols RJ; Greggio E; Kortholt A; Galli T; Chartier-Harlin MC; Taymans JM
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.
    Nguyen AP; Moore DJ
    Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.
    Blanca Ramírez M; Lara Ordóñez AJ; Fdez E; Madero-Pérez J; Gonnelli A; Drouyer M; Chartier-Harlin MC; Taymans JM; Bubacco L; Greggio E; Hilfiker S
    Hum Mol Genet; 2017 Jul; 26(14):2747-2767. PubMed ID: 28453723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.
    Xiong Y; Yu J
    Trends Mol Med; 2024 Oct; 30(10):982-996. PubMed ID: 39153957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
    Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
    Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 signaling in neurodegeneration: two decades of progress.
    Iannotta L; Greggio E
    Essays Biochem; 2021 Dec; 65(7):859-872. PubMed ID: 34897411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of LRRK2: from kinase to substrate.
    Lobbestael E; Baekelandt V; Taymans JM
    Biochem Soc Trans; 2012 Oct; 40(5):1102-10. PubMed ID: 22988873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death.
    Yoon JH; Mo JS; Kim MY; Ann EJ; Ahn JS; Jo EH; Lee HJ; Lee YC; Seol W; Yarmoluk SM; Gasser T; Kahle PJ; Liu GH; Belmonte JCI; Park HS
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2356-2368. PubMed ID: 28888991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson's disease.
    Gonzalez-Hunt CP; Thacker EA; Toste CM; Boularand S; Deprets S; Dubois L; Sanders LH
    Sci Rep; 2020 Oct; 10(1):17293. PubMed ID: 33057100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.
    Fujimoto T; Kuwahara T; Eguchi T; Sakurai M; Komori T; Iwatsubo T
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1708-1715. PubMed ID: 29223392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
    Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
    Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Gómez-Suaga P; Waschbüsch D; Lobbestael E; Baekelandt V; Nairn AC; Ruiz-Martínez J; Aiastui A; López de Munain A; Lis P; Comptdaer T; Taymans JM; Chartier-Harlin MC; Beilina A; Gonnelli A; Cookson MR; Greggio E; Hilfiker S
    Mol Neurodegener; 2018 Jan; 13(1):3. PubMed ID: 29357897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?
    Taymans JM; Mutez E; Drouyer M; Sibran W; Chartier-Harlin MC
    Biochem Soc Trans; 2017 Feb; 45(1):207-212. PubMed ID: 28202674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Type II LRRK2 inhibitors on signaling and mitophagy.
    Tasegian A; Singh F; Ganley IG; Reith AD; Alessi DR
    Biochem J; 2021 Oct; 478(19):3555-3573. PubMed ID: 34515301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 dephosphorylation increases its ubiquitination.
    Zhao J; Molitor TP; Langston JW; Nichols RJ
    Biochem J; 2015 Jul; 469(1):107-20. PubMed ID: 25939886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.